Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Inflammatory Bowel Diseases
|
November 4, 2009
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis
Milan Lukas, Pavel Drastich, Michal Konecny, et al.
Scandinavian Journal of Gastroenterology
|
July 10, 2013
Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study
Martin Bortlik, Nadezda Machkova, Dana Duricova, et al.
Inflammatory Bowel Diseases
|
December 9, 2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
Bruce E Sands, William J Sandborn, Gert Van Assche, et al.
European Journal of Pediatrics
|
July 18, 2024
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort
Katarina Mitrova, Karin Cerna, Kristyna Zdychyncova, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
July 11, 2009
Association of IL23R p.381Gln and ATG16L1 p.197Ala with Crohn disease in the Czech population
Petra Dusatkova, Ondrej Hradsky, Martin Lenicek, et al.
Dermatologic Therapy
|
June 7, 2014
Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences
Katerina Juzlova, Jana Votrubova, Denisa Kacerovska, et al.
Gastroenterology
|
February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
Stephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.
Gastrointestinal Endoscopy
|
March 5, 2025
Risk factors for difficult endoscopic bowel dilation of predominantly shorter and noninflammatory strictures among patients with inflammatory bowel disease: findings from inflammatory bowel disease tertiary centers in Poland and Czech Republic
Konrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Gastrointestinal Endoscopy
|
July 16, 2025
Response
Konrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Scandinavian Journal of Gastroenterology
|
September 3, 2015
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
Martin Bortlik, Dana Duricova, Nadezda Machkova, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Inflammatory Bowel Diseases
|
November 4, 2009
Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis
Milan Lukas, Pavel Drastich, Michal Konecny, et al.
Scandinavian Journal of Gastroenterology
|
July 10, 2013
Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study
Martin Bortlik, Nadezda Machkova, Dana Duricova, et al.
Inflammatory Bowel Diseases
|
December 9, 2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy
Bruce E Sands, William J Sandborn, Gert Van Assche, et al.
European Journal of Pediatrics
|
July 18, 2024
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort
Katarina Mitrova, Karin Cerna, Kristyna Zdychyncova, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
July 11, 2009
Association of IL23R p.381Gln and ATG16L1 p.197Ala with Crohn disease in the Czech population
Petra Dusatkova, Ondrej Hradsky, Martin Lenicek, et al.
Dermatologic Therapy
|
June 7, 2014
Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences
Katerina Juzlova, Jana Votrubova, Denisa Kacerovska, et al.
Gastroenterology
|
February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
Stephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.
Gastrointestinal Endoscopy
|
March 5, 2025
Risk factors for difficult endoscopic bowel dilation of predominantly shorter and noninflammatory strictures among patients with inflammatory bowel disease: findings from inflammatory bowel disease tertiary centers in Poland and Czech Republic
Konrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Gastrointestinal Endoscopy
|
July 16, 2025
Response
Konrad Lewandowski, Martin Lukas, Magdalena Kaniewska, et al.
Scandinavian Journal of Gastroenterology
|
September 3, 2015
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
Martin Bortlik, Dana Duricova, Nadezda Machkova, et al.
Page
of 8